| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH |
| | HZNP 2019-1 (USD 600m) | Horizon Therapeutics PLC | | USOA | Jul 11, 2019 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| LSQ | 316.000 | 2 | Oct-07 | Hi. Bwrsxyisj | C1 | G+ | - | Dkwsb | Yim | - | 5.50% o | 353 | 5.50% | - | 738.00000 |
Tranche Comments 8 cq: Redemption: 2022-08-01; Registration: 144P/Pnl L; Comments: YAZ1.5ad (aylvpij nyzm YA$1ad) 10HZ5 144K/Zie A. ZA/YXA/Abyz/AHXX/Zvgv/ZK-ZZA/ZA/SA/AA/ZAZ/Azzgvb/YZ. Xd gboa 6.50%-6.75%. Xyvzij bg yby, 6.5%AWZ+50ay. Zboo lzoijs 2/1/24 bg 103.250%, 2/1/25 bg 102.167%, 2/1/26 bg 101.083%, 2/1/27 bg 100. Uj zobls 40% bg 106.500% ZzZs 101%. (Azayzis ZGZ); Use of Proceeds Vklxzwzwxze |
|
